Robert Schrepfer

2020

In 2020, Robert Schrepfer earned a total compensation of $2.7M as Former Senior Vice President, New Business Development and Specialty Sales at ANI Pharmaceuticals, a 23% increase compared to previous year.

Compensation breakdown

Bonus$288,792
Salary$474,273
Stock Awards$1,877,400
Other$18,498
Total$2,658,963

Schrepfer received $1.9M in stock awards, accounting for 71% of the total pay in 2020.

Schrepfer also received $288.8K in bonus, $474.3K in salary and $18.5K in other compensation.

Rankings

In 2020, Robert Schrepfer's compensation ranked 4,317th out of 13,090 executives tracked by ExecPay. In other words, Schrepfer earned more than 67.0% of executives.

ClassificationRankingPercentile
All
4,317
out of 13,090
67th
Division
Manufacturing
1,749
out of 5,621
69th
Major group
Chemicals And Allied Products
683
out of 2,254
70th
Industry group
Drugs
584
out of 1,954
70th
Industry
Pharmaceutical Preparations
444
out of 1,459
70th
Source: SEC filing on April 29, 2021.

Schrepfer's colleagues

We found five more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2020.

2020

Nikhil Lalwani

ANI Pharmaceuticals

Chief Executive Officer

2020

Stephen Carey

ANI Pharmaceuticals

Chief Financial Officer

2020

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

2020

Patrick Walsh

ANI Pharmaceuticals

Chief Executive Officer

2020

Arthur Przybyl

ANI Pharmaceuticals

Chief Executive Officer

News

You may also like